Com-Cov study reports ‘Mix and match’ of COVID-19 vaccines provides good protection against virus

In study where participants were given either standard 2 doses of AZ or Pfizer/BioNTech vaccines or a combination of the two, both mixed schedules induced high antibody levels against the SARS-CoV-2 virus when doses were administered four weeks apart.

Source:

PharmaTimes